The diagnostic and clinical success of standardization of BCR-ABL1 p210 monitoring in chronic myeloid leukemia patients could be seen as a good example for further standardization of molecular monitoring in other gene rearrangements. The gene discussed is EVPL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.